Curanex Pharmaceuticals Inc
CURX
$0.31
$0.000.07%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 488.18% | 332.30% | 135.16% | 163.27% | 261.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1,995.20% | 1,359.75% | 429.17% | 163.27% | 261.06% |
| Operating Income | -1,995.20% | -1,359.75% | -429.17% | -163.27% | -261.06% |
| Income Before Tax | -1,627.79% | -1,068.77% | -468.51% | -217.29% | -335.45% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,627.79% | -1,068.77% | -468.51% | -217.29% | -335.45% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,627.79% | -1,068.77% | -468.51% | -217.29% | -335.45% |
| EBIT | -1,995.20% | -1,359.75% | -429.17% | -163.27% | -261.06% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -294.52% | 20.60% | 76.75% | 71.25% | 59.01% |
| Normalized Basic EPS | -306.27% | 19.70% | 77.56% | 72.27% | 60.14% |
| EPS Diluted | -270.29% | 18.38% | 74.72% | 68.76% | 56.33% |
| Normalized Diluted EPS | -306.27% | 19.70% | 77.56% | 72.27% | 60.14% |
| Average Basic Shares Outstanding | 53.56% | 122.47% | 1,800.60% | 2,062.76% | 2,784.84% |
| Average Diluted Shares Outstanding | 53.56% | 122.47% | 1,800.60% | 2,062.76% | 2,784.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |